| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Alignment Healthcare, Inc.'s insiders have reduced their positions by a net 1,066,967 shares worth roughly $13.7M. In the past 30 days, 0 insiders bought and 1 sold.
The insider who sold still holds shares after the sale.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 13.48M | $99.59M | - | |
| 10% | 13.48M | $99.59M | - | |
| VP | 1.08M | $7.98M | - | |
| Pres | 794.6K | $5.87M | - | |
| CEO | 590.8K | $4.37M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 11, 2024 | Robert Thomas Freeman58 | Chief Financial Officer | Sell10b5-1 | 30,500 | $13.42 | $409,355.75 | -24.7% | +7.2% | +22.4% | |
| Nov 4, 2024 | Hakan Kardes | Chief Experience Officer | Sell10b5-1 | 25,000 | $13.04 | $326,112.40 | -6.6% | +15.7% | +28.6% | |
| Oct 31, 2024 | Robert Thomas Freeman58 | Chief Financial Officer | Sell10b5-1 | 40,680 | $12.04 | $489,838.08 | -24.8% | +23.5% | +36.0% | |
| Oct 15, 2024 | Dawn Christine Maroney57 | President, Markets | Sell10b5-1 | 30,000 | $10.77 | $323,082.00 | -1.7% | +24.3% | +59.4% | |
| Oct 14, 2024 | Robert Thomas Freeman58 | Chief Financial Officer | Sell10b5-1 | 30,500 | $11.50 | $350,872.00 | -15.7% | +18.5% | +51.5% | |
| Oct 9, 2024 | John E Kao68 | Chief Executive Officer | Sell10b5-1 | 90,000 | $11.33 | $1,019,538.00 | -3.4% | +3.5% | +54.9% | |
| Oct 8, 2024 | Hyong Kim56 | Chief Medical Officer | Sell | 22,460 | $11.03 | $247,733.80 | -4.0% | -3.4% | +50.9% | |
| Oct 8, 2024 | Robert Thomas Freeman58 | Chief Financial Officer | Sell10b5-1 | 39,320 | $12.04 | $473,349.89 | -16.8% | -3.4% | +50.9% | |
| Oct 2, 2024 | Robert Thomas Freeman58 | Chief Financial Officer | Sell10b5-1 | 30,500 | $10.76 | $328,256.17 | -11.5% | -0.1% | +42.5% | |
| Oct 1, 2024 | Christopher J Joyce47 | Chief Legal and Admin. Officer | Sell10b5-1 | 667 | $11.79 | $7,865.73 | -0.2% | +11.6% | +68.2% |